Tuhura Biosciences, Inc. (HURA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tuhura Biosciences, Inc., a Nevada corporation, on June 26, 2025, regarding events occurring on June 23, 2025. The report discloses the formal filing of a Certificate of Amendment to the Company's Articles of Incorporation with the Nevada Secretary of State following stockholder approval at a Special Meeting in Lieu of an Annual Meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure changes rather than financial performance.
Material Changes
- Authorized Common Stock: Increased from 75,000,000 shares to 200,000,000 shares.
- Authorized Preferred Stock: Remains at 5,000,000 shares.
- Par Value: Both common and preferred stock maintain a par value of $0.001 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to notify the market of the completed amendment to the Articles of Incorporation.
Key Facts for Investor Verification
- Verify the exact number of outstanding shares versus the new authorized limit of 200 million.
- Confirm the date of the Special Meeting (June 23, 2025) and the filing date with the Nevada Secretary of State.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for any additional covenants or restrictions not summarized in the text.